News
-
Australian Clinical Trials shine at annual ACTA Awards
The Australian clinical trials sector was celebrated at the 2024 ACTA Trial of the Year Awards ceremony, held on International Clinical Trials Day, Monday 20 May 2024.
-
ACTA welcomes $1.89b investment in Australian health and medical research including support for a National One Stop Shop
ACTA congratulate the Albanese Government’s announcement of a $1.89billion investment towards Australian health and medical research through its new ‘Health Research for a Future Made in Australia’ package.
-
Embedding stakeholder preferences in setting priorities for health research: Using a discrete choice experiment to develop a multi-criteria tool for evaluating research proposals
The prestigious Plos One journal has just released a groundbreaking paper titled ‘Embedding Stakeholder Preferences in Setting Priorities for Health Research: using a discrete choice experiment to develop a multi-criteria tool for evaluating research proposals PONE-D-22-25100R1’.
Search News
General search and filters
Filter by:
Topics
Results filtered by:
-
Australian Clinical Trials shine at annual ACTA Awards
-
ACTA welcomes $1.89b investment in Australian health and medical research including support for a National One Stop Shop
-
Good Statistical Practice: development of tailored Good Clinical Practice training for statisticians
-
Register to attend the 2024 Trial of the Year Awards
-
Workshop: National Clinical Trials Governance Framework: Update from sites that have been through accreditation
-
Nominations now closed : 2024 ACTA Trial of the Year Awards
-
Insights from the ACTA STInG 2023 annual members meeting
-
Embedding stakeholder preferences in setting priorities for health research: Using a discrete choice experiment to develop a multi-criteria tool for evaluating research proposals
-
2023 ACTA International Clinical Trials Symposium
-
Winner Announced for the Australian Clinical Trials Alliance 2023 Trial of the Year Award
-
Media Release: PHRP Excellence Awards – Highly Commended In Practice paper
-
ACTA congratulates ALLG on 50 years of clinical trials impact